SAB0 Stock Chart & Stats
€13.10
-€0.30(-2.24%)
At close: 4:00 PM EDT
€13.10
-€0.30(-2.24%)
Day’s Range― - ―
52-Week Range€10.90 - €15.80
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€6.55B
Enterprise Value€11.16K
Total Cash (Recent Filing)€556.57M
Total Debt (Recent Filing)€7.34B
Price to Earnings (P/E)19.7
Beta0.20
Next Earnings
Aug 20, 2026EPS Estimate
0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.81
Shares Outstanding494,237,950
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.57
Price to Sales (P/S)1.35
P/FCF Ratio13.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.79
Revenue Forecast (FY)€6.81B
Bulls Say, Bears Say
Bulls Say
Cash GenerationSonic's very strong free cash flow growth and high earnings-to-cash conversion demonstrate durable internal funding capacity. Over the next 2–6 months this supports capex for lab upgrades, dividend continuity, debt reduction and selective M&A without relying on volatile external financing.
Revenue And Margin MomentumConsistent organic growth across core markets alongside modest margin expansion indicates resilient underlying demand for diagnostic services. This mix-driven revenue growth and stable margin trajectory support sustainable earnings and pricing leverage via indexation and higher-complexity testing.
Scale, M&A Integration & Digital CapabilitiesProgress integrating acquisitions and scaling proprietary digital pathology creates structural competitive advantages: broader test menu, national platform economics and workflow efficiencies. These durable assets should drive longer-term share gains and margin improvement as synergies and digital adoption mature.
Bears Say
U.S. Operations Margin PressureSustained margin weakness in the U.S., a key profit pool, requires successful restructuring and revenue lift to restore profitability. If cost rationalisation or collection improvements underdeliver, U.S. margins could structurally lag peers and drag consolidated operating margins over the medium term.
Working Capital And Short-term Leverage StrainBilling disruptions and acquisition-related capex increased debtors and net debt, pressuring liquidity and working capital. Until collections normalise and sale-and-leaseback actions materialise, elevated short-term leverage can constrain investment flexibility and raise refinancing risk in tighter credit conditions.
Regulatory And Wage UncertaintyPending fee-schedule changes in Germany and potential wage rulings in Australia create durable reimbursement and cost uncertainty. Adverse regulatory outcomes or higher wage baselines would compress margins and require either higher prices from payers or operational offsets, limiting cashflow resilience.
Sonic Healthcare News
SAB0 FAQ
What was Sonic Healthcare Limited’s price range in the past 12 months?
Sonic Healthcare Limited lowest stock price was €10.90 and its highest was €15.80 in the past 12 months.
What is Sonic Healthcare Limited’s market cap?
Sonic Healthcare Limited’s market cap is €6.55B.
When is Sonic Healthcare Limited’s upcoming earnings report date?
Sonic Healthcare Limited’s upcoming earnings report date is Aug 20, 2026 which is in 18 days.
How were Sonic Healthcare Limited’s earnings last quarter?
Sonic Healthcare Limited released its earnings results on Feb 18, 2026. The company reported €0.306 earnings per share for the quarter, missing the consensus estimate of €0.309 by -€0.003.
Is Sonic Healthcare Limited overvalued?
According to Wall Street analysts Sonic Healthcare Limited’s price is currently Overvalued.
Does Sonic Healthcare Limited pay dividends?
Sonic Healthcare Limited does not currently pay dividends.
What is Sonic Healthcare Limited’s EPS estimate?
Sonic Healthcare Limited’s EPS estimate is 0.4.
How many shares outstanding does Sonic Healthcare Limited have?
Sonic Healthcare Limited has 494,237,950 shares outstanding.
What happened to Sonic Healthcare Limited’s price movement after its last earnings report?
Sonic Healthcare Limited reported an EPS of €0.306 in its last earnings report, missing expectations of €0.309. Following the earnings report the stock price went up 6.202%.
Which hedge fund is a major shareholder of Sonic Healthcare Limited?
Currently, no hedge funds are holding shares in DE:SAB0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sonic Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-7.10%
12-Months-Change
Fundamentals
Return on Equity
4.86%
Trailing 12-Months
Asset Growth
19.27%
Trailing 12-Months
Company Description
Sonic Healthcare Limited
Headquartered in Sydney, Australia, Sonic Healthcare Limited, established in 1934, is a global provider of medical diagnostic and healthcare services. The company delivers a comprehensive range of laboratory medicine (pathology) services, alongside extensive diagnostic imaging and radiology capabilities, which include MRI, CT scans, ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Beyond diagnostics, Sonic Healthcare also offers various primary care medical solutions. These encompass general practitioner services, occupational health support, remote healthcare provisions, community and in-home nursing, primary care research initiatives, health assessment technologies, clinical trial management, and chronic disease management programs. These crucial services are extended to medical professionals, hospitals, community health organizations, and their respective patients. Furthermore, the company provides administrative support and facilities to medical practitioners. Sonic Healthcare maintains a significant international presence, operating across Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland.